Posters
« Back
Determining equivalency of generic and name brand oral suspensions using zeta potential
EP23945
Poster Title: Determining equivalency of generic and name brand oral suspensions using zeta potential
Submitted on 06 Apr 2016
Author(s): J.G. Saad, M. Scoggins, D. Sowle
Affiliations: Micromeritics Instrument Corporation
This poster was presented at Pittcon 2016
Poster Views: 1,213
View poster »


Poster Information
Abstract: Suspension stability plays a role in the taste and texture of an oral suspension containing one or more active pharmaceutical ingredients (API). The effects of aggregating or flocculating nanoparticles or emulsions can impact this key component where generic oral suspension must demonstrate equivalency to name brand oral suspensions. Zeta potential can be used to quantify and control suspension stability and the formation of aggregates and flocculants, thereby optimizing the taste and texture of a generic oral suspension to match the name brand product. A generic and a name brand oral suspension are visually compared as a qualitative test. The electrophoretic mobility of each suspension is then determined using electrophoretic light scattering (ELS) technology. From the electrophoretic mobility, the electrical potential of a particle or emulsion at the shear or slipping plane or zeta potential, is determined. The larger the absolute millivolt (mV) value of zeta potential, the more stable a suspension will be and the more likely the particles or emulsions will repel each other rather than flocculate. The generic formulation shows zeta potential values that are much smaller than the name brand oral suspension. Visually, the generic oral suspension shows signs of settling and requires shaking before sampling. The generic formulation may require the addition of additives that can increase the zeta potential to the levels of the name brand and aid in stabilizing the suspension.Summary: Zeta potential can be used to quantify and control suspension stability and the formation of aggregates and flocculants, thereby optimizing the taste and texture of a generic oral suspension to match the name brand product. Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Diagnostic outcomes of MRE as an investigation for NSS of small bowel disease: Can CTE be a cost-effective alternative in patients above 50 years old?
K ElGendy, E Musgrave, M Twemlow

An audit on compliance with the Ottawa Knee Rule in patients with traumatic knee pain
Qasim Afzaal, Saad SIddiqui, Amit Shah

Bleeding Pseudoaneurysm in uncommon locations: interesting cases from St. Peter's Hospital
Dr Joel James (SHO) Dr Chandni Patel (SpR) & Dr Shirish Prabhudesai (Consultant)

Estimating the Mass of the Milky Way Galaxy
Celeste Artiga, Yilun Ma, Ayla Weitz, Alex Ye (Mentor)

An Analysis on the Distribution of the Hubble Parameter across the Sky
Stephanie Bie, Arnav Gulati, Jwalin Joshi, Richard Yu, & Xuyang Yu / Mentors: Yukei Murakami & Andrew Hoffman